Retatrutide
Next-generation triple agonist (GLP-1 / GIP / Glucagon).
An investigational triple-receptor agonist studied for its role in metabolic regulation, appetite signalling and energy expenditure. One of the most studied compounds in the next generation of GLP-1 research.
No payment now — reserve to lock in allocation from the first release batch.
